Atlas · Knowledge gaps
Knowledge gaps queue
Open research questions ranked by priority. Each gap is a candidate for a debate or a SPEC-033 bounty challenge.
13
open gaps
| # | Title | Status | Priority | Domain | Created | |
|---|---|---|---|---|---|---|
| 1 | What are the safety thresholds for ketone-induced disruption of astrocytic gluc… While metabolic steal syndrome was identified as a concern, human-relevant safety data for ketone-mediated astrocyte dysfunction is lacking. This knowledge gap … gap-debate-20260410-112343-7902affa | open | 0.850 | neurotoxicology | 2026-04-10 | Open → |
| 2 | What are the long-term safety implications of chronic circadian rhythm manipula… While short-term efficacy was discussed, the debate did not address potential consequences of sustained circadian intervention on microglial homeostatic functio… gap-debate-20260410-095945-bc40f32d | open | 0.800 | neurotoxicology | 2026-04-10 | Open → |
| 3 | Why do higher UV-328 concentrations paradoxically reduce neurotoxicity despite… The abstract reports that neurotoxic effects were 'partially attenuated at higher concentrations of UV-328' - a counterintuitive dose-response relationship. Thi… gap-pubmed-20260410-171638-233dc3d7 | open | 0.800 | neurotoxicology | 2026-04-10 | Open → |
| 4 | What is the direct molecular mechanism linking aconitine exposure to AMPK phosp… The study shows aconitine reduces AMPK phosphorylation and that AMPK activation rescues the phenotype, but the direct molecular pathway connecting aconitine to … gap-pubmed-20260410-174152-025cf556 | open | 0.800 | neurotoxicology | 2026-04-10 | Open → |
| 5 | What mechanisms drive the temporal paradox of cognitive recovery despite contin… The study shows cognitive impairments at 4 weeks that recover by 8 weeks despite ongoing particulate matter exposure. This counterintuitive recovery pattern sug… gap-pubmed-20260410-181410-7b91c95a | open | 0.800 | neurotoxicology | 2026-04-10 | Open → |
| 6 | What are the long-term toxicity effects of sustained TFEB overactivation in neu… The skeptic raised concerns about chronic TFEB activation potentially causing lysosomal storage disorders, but no safety data was provided. This safety profile … gap-debate-20260410-100428-1f22e42a | open | 0.800 | neurotoxicology | 2026-04-10 | Open → |
| 7 | How do genetic polymorphisms in drug metabolism modulate methamphetamine neurot… The abstract identifies genetic polymorphism as a key factor determining toxicity extent but doesn't explain how these variants mechanistically alter the molecu… gap-pubmed-20260410-193809-dd4c2de9 | open | 0.790 | neurotoxicology | 2026-04-10 | Open → |
| 8 | Why do nanoplastics cause neuron loss while microplastics cause dendritic spine… The study shows size-dependent differential neurotoxic mechanisms - NPs (0.5 μm) induce neuronal death while MPs (5 μm) cause synaptic damage. The molecular bas… gap-pubmed-20260411-071402-601c22fa | open | 0.790 | neurotoxicology | 2026-04-11 | Open → |
| 9 | How can understanding methamphetamine toxicity mechanisms inform treatment stra… The abstract states this understanding is 'essential' for developing treatments but doesn't specify which pathways are most therapeutically tractable or how mec… gap-pubmed-20260410-193809-1113b2e8 | open | 0.760 | neurotoxicology | 2026-04-10 | Open → |
| 10 | What are the causal relationships between epigenetic changes and neurotoxic dam… The abstract mentions neurotoxicology as an area of neuroepigenetic impact but doesn't establish whether epigenetic modifications cause, result from, or modulat… gap-pubmed-20260411-093953-55fc7323 | open | 0.740 | neurotoxicology | 2026-04-11 | Open → |
| 11 | What determines tissue-specific activation of different methamphetamine toxicit… Multiple distinct molecular pathways are listed but the abstract doesn't explain why certain pathways predominate in specific organs (brain vs heart vs kidney).… gap-pubmed-20260410-193809-eab179e9 | open | 0.740 | neurotoxicology | 2026-04-10 | Open → |
| 12 | What molecular mechanism explains how FB1 inhibits ceramide synthases? The authors explicitly state that the molecular mechanism of CerS inhibition by FB1 remains unknown, despite its well-established inhibitory effects. Understand… gap-pubmed-20260411-075342-a144996a | open | 0.640 | neurotoxicology | 2026-04-11 | Open → |
| 13 | Why does FB1 cause opposite effects on ceramide levels in lung versus liver? The study reveals a striking contradiction where FB1 decreases ceramide content by half in lungs but increases it 3.5-fold in liver. This tissue-specific parado… gap-pubmed-20260411-075342-a4fd4ffc | open | 0.620 | neurotoxicology | 2026-04-11 | Open → |